Log in
Enquire now
‌

US Patent 11254695 Soluble C5aR antagonists

Patent 11254695 was granted and assigned to ChemoCentryx on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
ChemoCentryx
ChemoCentryx
0
Current Assignee
ChemoCentryx
ChemoCentryx
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112546950
Patent Inventor Names
Venkat Reddy Mali0
Valentino J. Stella0
Yibin Zeng0
Yang Song0
Antoni Krasinski0
Penglie Zhang0
Pingchen Fan0
Shichang Miao0
...
Date of Patent
February 22, 2022
0
Patent Application Number
166609940
Date Filed
October 23, 2019
0
Patent Citations
‌
US Patent 10329314 Soluble C5aR antagonists
0
‌
US Patent 10487098 Soluble C5aR antagonists
Patent Primary Examiner
‌
Sahar Javanmard
0
Patent abstract

Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11254695 Soluble C5aR antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.